Intestinal neuronal dysplasia

From WikiMD's Wellness Encyclopedia

Intestinal Neuronal Dysplasia (IND) is a congenital condition characterized by an abnormal organization of nerve cells (neurons) in the intestines. This disorder falls under the broader category of neurogastrointestinal disorders, which affect the nervous system's control over the gastrointestinal tract. IND is specifically classified into two types: Type A and Type B, with Type B being more common. The condition primarily affects the enteric nervous system, which is responsible for managing the functions of the gastrointestinal tract, leading to a range of digestive symptoms.

Symptoms and Diagnosis[edit | edit source]

The symptoms of IND can vary widely among individuals but commonly include chronic constipation, abdominal pain, bloating, and in severe cases, intestinal obstruction. These symptoms often present in infancy or early childhood. Diagnosis of IND involves a combination of clinical evaluation, imaging studies, and histological examination of intestinal tissue obtained through biopsy. The hallmark of IND on histological examination is the presence of hyperplasia (increased number) of ganglion cells in the myenteric (Auerbach's) plexus, particularly noted in Type B IND.

Etiology[edit | edit source]

The exact cause of IND remains unclear, but it is believed to involve genetic and environmental factors. Some studies suggest a familial predisposition to the condition, indicating a possible genetic component. However, the specific genes involved have not been conclusively identified.

Treatment[edit | edit source]

Treatment for IND is primarily symptomatic and supportive. Management strategies may include dietary modifications, laxatives, and in some cases, surgical intervention to relieve severe constipation or intestinal obstruction. The approach to treatment is highly individualized, depending on the severity of the symptoms and the specific needs of the patient.

Prognosis[edit | edit source]

The prognosis for individuals with IND varies. Many affected individuals can manage their symptoms effectively with appropriate treatment and lead normal, healthy lives. However, some may experience persistent or severe symptoms that require ongoing management.

Epidemiology[edit | edit source]

The prevalence of IND is difficult to determine due to variations in diagnostic criteria and reporting. It is considered a rare condition, with Type B being more commonly reported than Type A.

See Also[edit | edit source]

References[edit | edit source]



WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD